Biomarkers for diagnosis and prognosis of bladder cancer and uses thereof

摘要

The present invention relates to a biomarker consisting of 8 gene combinations associated with the progression of bladder cancer and its use. The bladder cancer risk assessment model developed using the eight bladder cancer progression-related genes according to the present invention has been clinically confirmed to be able to effectively predict the recurrence of bladder cancer and the progression of the cancer. Therefore, the biomarker set composed of the above genes can be used as a marker for bladder cancer diagnosis and prognosis measurement, and thus it is possible to diagnose bladder cancer with high accuracy and reliability and to predict the prognosis of the bladder cancer, .